PVCT - PROVECTUS BIOPHARMACEUTICALS, INC.
0.0979
0.004 3.575%
Share volume: 20,835
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.09
0.00
0.04%
View ratios
Fiscal Date | 09-30-2024 | 12-31-2024 | |
---|---|---|---|
Fiscal Quarter | Q3 2024 | Q4 2024 | |
Report Date | 11-12-2024 | 03-27-2025 | |
Total revenue | 109.745 K | 14.332 K | |
Cost of revenue | 0.000 | 0.000 | |
Gross profit | 109.745 K | 14.332 K | |
-86.94% | |||
Operating expenses | 1.065 M | 2.349 M | |
Selling general and admin | 651.486 K | 1.792 M | |
Research and development | 413.987 K | 556.678 K | |
Total expenses | 1.065 M | 2.349 M | |
120.45% | |||
Operating income | -955.728 K | -2.335 M | |
Ebit | -955.728 K | -2.335 M | |
Pretax income | -1.014 M | -2.397 M | |
136.30% | |||
Income tax | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | |
Net income | -1.014 M | -2.397 M | |
-136.30% |